Review Article
Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
Table 3
Protocol of monochemotherapy treatment for MF/SS in Egypt.
| | Monochemotherapy | Regimen | Stage | OCEBM |
| | Methotrexate [8, 13, 79, 80] | 25–50 mg/week for 3–6 m | IIB, III, SS 2nd: IA-IIA | Level 4 | | Gemcitabine [8, 13, 79, 81] | 1200 mg/m2 IV on days 1, 8, 15 of a 28-day schedule for 3–6 m | IV 2nd: IIB, III | Level 4 | | Pegylated liposomal doxorubicin [8, 13, 80, 82] | 20–30 mg/m2 IV, every 3-4 weeks for 12–24 weeks | IV 2nd: IIB, III | Level 3 |
|
|
OCEBM: Oxford Centre for Evidence-Based Medicine.
|
